Human Genome Epidemiology Literature Finder
|
Records 1 - 21 (of 21 Records) |
| Query Trace: Sarcoma and CDKN2A[original query] |
|---|
| Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations. Cancer discovery 2014 Nov 4 (11): 1342-53. Tirode Franck, Surdez Didier, Ma Xiaotu, Parker Matthew, Le Deley Marie Cécile, Bahrami Armita, Zhang Zhaojie, Lapouble Eve, Grossetête-Lalami Sandrine, Rusch Michael, Reynaud Stéphanie, Rio-Frio Thomas, Hedlund Erin, Wu Gang, Chen Xiang, Pierron Gaelle, Oberlin Odile, Zaidi Sakina, Lemmon Gordon, Gupta Pankaj, Vadodaria Bhavin, Easton John, Gut Marta, Ding Li, Mardis Elaine R, Wilson Richard K, Shurtleff Sheila, Laurence Valérie, Michon Jean, Marec-Bérard Perrine, Gut Ivo, Downing James, Dyer Michael, Zhang Jinghui, Delattre Olivier, |
| The genomic landscape of the Ewing Sarcoma family of tumors reveals recurrent STAG2 mutation. PLoS genetics 2014 Jul 10 (7): e1004475. Brohl Andrew S, Solomon David A, Chang Wendy, Wang Jianjun, Song Young, Sindiri Sivasish, Patidar Rajesh, Hurd Laura, Chen Li, Shern Jack F, Liao Hongling, Wen Xinyu, Gerard Julia, Kim Jung-Sik, Lopez Guerrero Jose Antonio, Machado Isidro, Wai Daniel H, Picci Piero, Triche Timothy, Horvai Andrew E, Miettinen Markku, Wei Jun S, Catchpool Daniel, Llombart-Bosch Antonio, Waldman Todd, Khan Jav |
| Copy number alterations and neoplasia-specific mutations in MELK, PDCD1LG2, TLN1, and PAX5 at 9p in different neoplasias. Genes, chromosomes & cancer 2014 Jul 53 (7): 579-88. Sarhadi Virinder Kaur, Lahti Leo, Scheinin Ilari, Ellonen Pekka, Kettunen Eeva, Serra Massimo, Scotlandi Katia, Picci Piero, Knuutila Saka |
| Tumoral TP53 and/or CDKN2A alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: a report from the Children's Oncology Group. Pediatric blood & cancer 2015 May 62 (5): 759-65. Lerman Daniel M, Monument Michael J, McIlvaine Elizabeth, Liu Xiao-qiong, Huang Dali, Monovich Laura, Beeler Natalie, Gorlick Richard G, Marina Neyssa M, Womer Richard B, Bridge Julia A, Krailo Mark D, Randall R Lor, Lessnick Stephen L, |
| Comparison of clinical features and outcomes in patients with extraskeletal versus skeletal localized Ewing sarcoma: A report from the Children's Oncology Group. Pediatric blood & cancer 2016 10 63 (10): 1771-9. Cash Thomas, McIlvaine Elizabeth, Krailo Mark D, Lessnick Stephen L, Lawlor Elizabeth R, Laack Nadia, Sorger Joel, Marina Neyssa, Grier Holcombe E, Granowetter Linda, Womer Richard B, DuBois Steven |
| A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis. Clinical sarcoma research 2019 9 9 12. Bui Nam Q, Przybyl Joanna, Trabucco Sally E, Frampton Garrett, Hastie Trevor, van de Rijn Matt, Ganjoo Kristen |
| Low mutation burden and frequent loss of CDKN2A/B and SMARCA2, but not PRC2, define premalignant neurofibromatosis type 1-associated atypical neurofibromas. Neuro-oncology 2019 2 21 (8): 981-992. Pemov Alexander, Hansen Nancy F, Sindiri Sivasish, Patidar Rajesh, Higham Christine S, Dombi Eva, Miettinen Markku M, Fetsch Patricia, Brems Hilde, Chandrasekharappa Settara C, Jones Kristine, Zhu Bin, Wei Jun S, , , Mullikin James C, Wallace Margaret R, Khan Javed, Legius Eric, Widemann Brigitte C, Stewart Douglas |
| Genomic Database Analysis of Uterine Leiomyosarcoma Mutational Profile. Cancers 2020 8 12 (8): . Astolfi Annalisa, Nannini Margherita, Indio Valentina, Schipani Angela, Rizzo Alessandro, Perrone Anna Myriam, De Iaco Pierandrea, Pirini Maria Giulia, De Leo Antonio, Urbini Milena, Secchiero Paola, Pantaleo Maria Abbondan |
| Cytomorphologic characteristics of next-generation sequencing-positive bile duct brushing specimens. Journal of the American Society of Cytopathology 2020 Jul . Rosenbaum Matthew W, Arpin Ronald, Limbocker Jessica, Casey Brenna, Le Long, Dudley Jonathan, Iafrate A John, Pitman Martha |
| Comprehensive molecular profiling to predict clinical outcomes in pancreatic cancer. Therapeutic advances in medical oncology 2021 9 13 17588359211038478. Hong Jung Yong, Cho Hee Jin, Kim Seung Tae, Park Young Suk, Shin Sang Hyun, Han In Woong, Lee Jeeyun, Heo Jin Seok, Park Joon |
| Genomic landscape of gliosarcoma: distinguishing features and targetable alterations. Scientific reports 2021 Sep 11 (1): 18009. Zaki Mark M, Mashouf Leila A, Woodward Eleanor, Langat Pinky, Gupta Saksham, Dunn Ian F, Wen Patrick Y, Nahed Brian V, Bi Wenya Lin |
| TP53 mutations increase radioresistance in rhabdomyosarcoma and Ewing sarcoma. British journal of cancer 2021 5 125 (4): 576-581. Casey Dana L, Pitter Kenneth L, Wexler Leonard H, Slotkin Emily K, Gupta Gaorav P, Wolden Suzanne |
| Evaluation of biomarkers, genetic mutations, and epigenetic modifications in early diagnosis of pancreatic cancer. World journal of gastroenterology 2021 10 27 (36): 6093-6109. Rah Bilal, Banday Manzoor Ahmad, Bhat Gh Rasool, Shah Omar J, Jeelani Humira, Kawoosa Fizalah, Yousuf Tahira, Afroze D |
| Molecular landscape and therapeutic alterations in Asian soft-tissue sarcoma patients. Cancer medicine 2022 May . Gan Meifu, Zhang Chen, Qiu Liqing, Wang Yue, Bao Hua, Yu Ruoying, Liu Rui, Wu Xue, Shao Yang, Hou Peifeng, Fei Zhengl |
| The prevalence and real-world therapeutic analysis of Chinese patients with KRAS-Mutant Non-Small Cell lung cancer. Cancer medicine 2022 4 11 (19): 3581-3592. Chen Hanxiao, Huang Dingzhi, Lin Gen, Yang Xue, Zhuo Minglei, Chi Yujia, Zhai Xiaoyu, Jia Bo, Wang Jingjing, Wang Yuyan, Li Jianjie, An Tongtong, Wu Meina, Wang Ziping, Zhao J |
| The landscape of genetic aberrations in myxofibrosarcoma. International journal of cancer 2022 4 151 (4): 565-577. Takeuchi Yasuhide, Yoshida Kenichi, Halik Adriane, Kunitz Annegret, Suzuki Hiromichi, Kakiuchi Nobuyuki, Shiozawa Yusuke, Yokoyama Akira, Inoue Yoshikage, Hirano Tomonori, Yoshizato Tetsuichi, Aoki Kosuke, Fujii Yoichi, Nannya Yasuhito, Makishima Hideki, Pfitzner Berit Maria, Bullinger Lars, Hirata Masahiro, Jinnouchi Keita, Shiraishi Yuichi, Chiba Kenichi, Tanaka Hiroko, Miyano Satoru, Okamoto Takeshi, Haga Hironori, Ogawa Seishi, Damm Freder |
| The landscape of alterations from 1407 ultra-rare sarcomas from the AACR GENIE database: Clinical implications. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 8 . Ryan A Denu, Justin T Moyers, Mohamed A Gouda, Anthony Conley, Alexander J Lazar, Vivek Subbi |
| Impact of KRAS subtype and concurrent pathogenic mutations on advanced non-small cell lung cancer outcomes. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2023 7 . Enrique Caballé-Perez, Norma Hernández-Pedro, Maritza Ramos-Ramírez, Pedro Barrios-Bernal, Eunice Romero-Núñez, José Lucio-Lozada, Santiago Ávila-Ríos, Gustavo Reyes-Terán, Andrés F Cardona, Oscar Arrie |
| BRAF mutations and concurrent alterations in patients with soft tissue sarcoma. Genes, chromosomes & cancer 2023 6 . Hiroshi Kobayashi, Liuzhe Zhang, Koichi Okajima, Yuki Ishibashi, Toshihide Hirai, Yusuke Tsuda, Masachika Ikegami, Hidenori Kage, Aya Shinozaki-Ushiku, Katsutoshi Oda, Sakae Tana |
| Identification of methyltransferase modification genes associated with prognosis and immune features of pancreatic adenocarcinoma. Molecular and cellular probes 2023 2 67 101897. Wang Wentao, Zhang Dongyuan, Chang Donglei, Li Yupeng, Ren L |
| Identification of germline cancer predisposition variants in pediatric sarcoma patients from somatic tumor testing. Scientific reports 2023 2 13 (1): 2959. Alba-Pavón Piedad, Alaña Lide, Gutierrez-Jimeno Miriam, García-Obregón Susana, Imízcoz Teresa, Panizo Elena, González-Urdiales Paula, Echebarria-Barona Aizpea, Lopez Almaraz Ricardo, Zaldumbide Laura, Astigarraga Itziar, Patiño-García Ana, Villate Ola |
- Page last reviewed:Feb 1, 2024
- Content source: